Achieving R0 resection in the colorectum using endoscopic submucosal dissection
British Journal of Surgery, 2007 Abstract Background Endoscopic mucosal resection is established for the removal of non-invasive colorectal tumours smaller than 20 mm but is unsatisfactory for larger lesions. Endoscopic submucosal dissection (ESD) enables en bloc resection of lesions larger than 20 mm.
D P, Hurlstone +5 more
openaire +2 more sources
Cirugía y Cirujanos, 2022 Background: We aimed to evaluate the effects of R0 and R1 resections after pancreatic surgery. Methods: Data of 130 patients were evaluated. Re-resection was performed in patients who were found to have R1 resection after frozen section (FS).
Orhan Aras, Rıdvan Yavuz
doaj +1 more source
Current Oncological Treatment of Patients with Pancreatic Cancer in Germany: Results from a National Survey on behalf of the Arbeitsgemeinschaft Internistische Onkologie and the Chirurgische Arbeitsgemeinschaft Onkologie of the Germany Cancer Society [PDF]
, 2009 Background: No data have previously been available regarding the current treatment of patients with pancreatic cancer (PC) in German hospitals and medical practices.
Boeck, Stefan +6 more
core +1 more source
Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer
Chronic Diseases and Translational Medicine, 2019 Objectives: Most patients with gallbladder cancer (GBC) present with advanced-stage disease and have a poor prognosis. Radical resection remains the only therapeutic option to improve survival in patients with GBC.
Chen Chen +7 more
doaj +1 more source
Transanal minimally invasive surgery for rectal lesions [PDF]
, 2016 Background and Objectives: Transanal minimally invasive surgery (TAMIS) has emerged as an alternative to transanal endoscopic microsurgery (TEM). The authors report their experience with TAMIS for the treatment of mid and high rectal tumors.
Balla, Andrea +7 more
core +1 more source
A case of distal extrahepatic cholangiocarcinoma with two positive resection margins [PDF]
, 2016 Cholangiocarcinoma is an uncommon primary malignancy of the biliary tract that is challenging to diagnose and treat effectively due to its relatively silent and late clinical presentation.
Andersen +42 more
core +2 more sources
Metastasized pancreatic carcinoma with neoadjuvant FOLFIRINOX therapy and R0 resection
World Journal of Gastroenterology, 2015 Patients with metastasized carcinoma of the pancreas have a very poor prognosis, and long-term survival cannot be expected. This case report describes two patients with an initial diagnosis of metastatic pancreatic cancer, both with hepatic metastases and one with an additional peritoneal carcinomatosis.
Sophie, Schneitler +6 more
openaire +2 more sources
Neoadjuvant treatment in pancreatic cance. Evidence-based medicine? A systematic review and meta-analysis [PDF]
, 2017 Neoadjuvant treatment in non-metastatic pancreatic cancer (PaC) has the theoretical advantages of downstaging the tumor, sterilizing any present systemic undetectable disease, selecting patients for surgery and administering therapy to each patient.
Antolino, Laura +10 more
core +1 more source
Asian Journal of Surgery, 2023 Objective: Although surgical resection offers the only chance of cure of perihilar cholangiocarcinoma and R1 resection has a poor prognosis, there is no consensus on optimal preoperative assessment of its longitudinal spread.
Hikaru Hayashi +9 more
doaj +1 more source
Radio-chemotherapy as a preoperative treatment for advanced rectal cancer. Evaluation of down-staging and morbidity [PDF]
, 2002 Background: The standard therapy for patients with clinically resectable rectal cancer is generally considered to be surgery, If the patient is diagnosed with advanced disease, postoperative radiochemotherapy (RCT) is usually recommended. In our study we
Dühmke, Eckhart +4 more
core +1 more source